This inventor holds 1 USPTO granted patent. Top assignee: Genelabs Technologies, Inc.. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Innovator Spotlight: Joshua Michael Gralapp
Introduction: Joshua Michael Gralapp is an accomplished inventor based in Sunnyvale, CA. He has made significant contributions to the field of pharmaceutical science, particularly in the development of compounds aimed at treating viral infections.
Latest Patents: Joshua holds one patent, titled "Bicyclic heteroaryl derivatives." This innovation involves the disclosure of compounds, compositions, and methods for treating infections caused by viruses from the Flaviviridae family. This patent represents a vital step forward in the search for effective treatments against these challenging viral diseases.
Career Highlights: Currently, Joshua is affiliated with Genelabs Technologies, Inc., where he has been involved in pioneering research and product development. His work has directly contributed to advancing the company's mission to develop novel therapeutic solutions.
Collaborations: Throughout his career, Joshua has collaborated with notable colleagues, including Franz Ulrich Schmitz and Christopher Don Roberts. These partnerships have been instrumental in fostering innovation and pushing the boundaries of research in their field.
Conclusion: Joshua Michael Gralapp exemplifies dedication and ingenuity in the realm of innovations. His patent on bicyclic heteroaryl derivatives showcases his commitment to addressing pressing health challenges. With ongoing collaborations and a promising career at Genelabs Technologies, Joshua remains a key figure in the fight against viral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile